These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 7192894
41. Characterization and stabilization of progesterone receptors in human benign prostatic hypertrophy. Bashirelahi N, Felder CC, Young JD. J Steroid Biochem; 1983 Jun; 18(6):801-9. PubMed ID: 6191129 [Abstract] [Full Text] [Related]
42. Antiprogestin-receptor complexes: differences in the interaction of the antiprogestin RU38,486 and the progestin R5020 with the progesterone receptor of human breast cancer cells. Mullick A, Katzenellenbogen BS. Biochem Biophys Res Commun; 1986 Feb 26; 135(1):90-7. PubMed ID: 3954780 [Abstract] [Full Text] [Related]
45. Characterization and properties of a progesterone receptor in the uterus of the quokka (Setonix brachyurus). Owen FJ, Cake MH, Bradshaw SD. J Endocrinol; 1982 Apr 26; 93(1):17-24. PubMed ID: 7200116 [Abstract] [Full Text] [Related]
46. Quantification of progesterone binding in mammary tissue of pregnant ewes. Smith JJ, Capuco AV, Akers RM. J Dairy Sci; 1987 Jun 26; 70(6):1178-85. PubMed ID: 3611473 [Abstract] [Full Text] [Related]
47. Evidence for specific progesterone receptors in rat brain cytosol. Greenstein BD. J Endocrinol; 1978 Dec 26; 79(3):327-38. PubMed ID: 744927 [Abstract] [Full Text] [Related]
48. Ionic and ligand-specific effects on the DNA binding of progesterone receptor bound to the synthetic progestin R5020 and the antiprogestin RU486. Chao CC, Thomas TJ, Ebede P, Gallo MA, Thomas T. Cancer Res; 1991 Aug 01; 51(15):3938-45. PubMed ID: 1855211 [Abstract] [Full Text] [Related]
49. Synthesis and evaluation of potential radioligands for the progesterone receptor. Hoyte RM, Rosner W, Johnson IS, Zielinski J, Hochberg RB. J Med Chem; 1985 Nov 01; 28(11):1695-9. PubMed ID: 4067997 [Abstract] [Full Text] [Related]
50. Simultaneous measurement of estrogen and progesterone receptors in tumor cytosols with use of 125I-labeled estradiol and of 3H-R5020. Thibodeau SN, Freeman L, Jiang NS. Clin Chem; 1981 May 01; 27(5):687-91. PubMed ID: 7194749 [Abstract] [Full Text] [Related]
51. Evidence for separate binding sites for progesterone and RU486 in the chick oviduct. Moudgil VK, Lombardo G, Hurd C, Eliezer N, Agarwal MK. Biochim Biophys Acta; 1986 Nov 28; 889(2):192-9. PubMed ID: 3778947 [Abstract] [Full Text] [Related]
53. Estrogen and progesterone receptors in the uterus of the vervet monkey. Potgieter HC, Spies JH, Klein T, Thierry M, van der Watt JJ. J Recept Res; 1985 Nov 28; 5(2-3):193-218. PubMed ID: 4040971 [Abstract] [Full Text] [Related]
54. Cytoplasmic progestin-receptors in guinea pig brain: characteristics and relationship to the induction of sexual behavior. Blaustein JD, Feder HH. Brain Res; 1979 Jun 29; 169(3):481-97. PubMed ID: 571753 [Abstract] [Full Text] [Related]
56. [Interaction of norethindrone on estrogen and progesterone receptors in the rabbit uterine cytosol (author's transl)]. Tamaya T, Ishihara S, Motoyama T, Nioka S, Furuta N. Nihon Naibunpi Gakkai Zasshi; 1975 Dec 20; 51(12):1033-42. PubMed ID: 183990 [Abstract] [Full Text] [Related]
57. Binding characteristics of the ovine membrane progesterone receptor alpha and expression of the receptor during the estrous cycle. Ashley RL, Arreguin-Arevalo JA, Nett TM. Reprod Biol Endocrinol; 2009 May 11; 7():42. PubMed ID: 19432978 [Abstract] [Full Text] [Related]
58. Progesterone, 5 alpha-dihydroprogesterone and R5020 binding in female rat anterior pituitary. Schenborn ET, Karavolas HJ. J Steroid Biochem; 1981 Jun 11; 14(6):523-31. PubMed ID: 7195444 [No Abstract] [Full Text] [Related]
59. Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors. Lin AL, McGill HC, Shain SA. Circ Res; 1982 May 11; 50(5):610-6. PubMed ID: 7200404 [Abstract] [Full Text] [Related]
60. Radioligand binding assay of progesterone receptors in the primate corpus luteum after in vivo treatment with the 3 beta-hydroxysteroid dehydrogenase inhibitor, trilostane. Slayden OD, Zelinski-Wooten MB, Stouffer RL, Brenner RM. J Clin Endocrinol Metab; 1994 Aug 11; 79(2):620-6. PubMed ID: 8045986 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]